EU Cyber Resilience Act Guide for Connected Laboratory Instrument Manufacturers

Connected laboratory instruments placed on the EU market — including mass spectrometers with remote diagnostic capability, automated liquid handling workstations with LIMS integration, scientific imaging systems with cloud synchronisation, chromatography data systems, and laboratory automation platforms — are products with digital elements under Article 3(1). Classification depends on the instrument's deployment context: research laboratory instruments used in academic or industrial R&D settings are likely Default-category products. Instruments deployed in clinical or regulated laboratory environments — such as GMP-compliant pharmaceutical quality control labs or clinical pathology laboratories — may qualify as Important Products Class I or Class II, particularly where result data influences patient care or regulated manufacturing release decisions. Vendors who sell the same instrument to both research and clinical markets must assess classification based on the highest-risk use case.

Laboratory instruments present specific security challenges: they often run specialised operating systems (frequently Windows-based) with long software lifecycles, are connected to proprietary instrument-control software, and are increasingly networked to LIMS and cloud platforms for data management. Annex I obligations include: ensuring Windows-based instrument computers receive operating system security updates, either through vendor-managed patch packages or through documented customer guidance; implementing access controls on instrument control software and data management interfaces; encrypting data transfers to LIMS, cloud repositories, and remote diagnostic services; eliminating default administrator credentials on instrument management consoles; and providing an authenticated mechanism for remote vendor service access that is auditable and revocable. The SBOM must cover both the vendor-supplied instrument software and any commercial or open-source components embedded in the software stack, including the operating system and instrument control libraries.

Article 13 requires a published CVD policy with a dedicated security reporting channel. For laboratory instrument manufacturers, the CVD programme must be capable of handling: vulnerability reports from scientific computing security researchers; reports from laboratory IT administrators who discover unexpected network behaviour; and internal findings from the vendor's own security testing programme. Because laboratory instruments are deployed in highly regulated environments — GMP pharmaceutical laboratories, accredited clinical laboratories — security advisories must be communicated in a format compatible with change control and qualification processes. When a security update is released, the vendor should provide customers with a qualification risk assessment summarising the security improvement and confirming that the update does not affect instrument performance or validated method results. This documentation supports customers' change control obligations under applicable quality regulations.

Article 14 requires notification to the relevant national CSIRT within 24 hours of confirmed active exploitation. For laboratory instrument vendors, exploitation scenarios typically involve remote access to instrument control software enabling data manipulation, exfiltration of proprietary research data, or disruption of automated analytical workflows. Vendors must maintain incident monitoring that covers both cloud-side services and on-premises instrument connectivity. The incident response plan must be capable of generating the 24-hour early warning notification while simultaneously investigating the full scope of exploitation across the installed customer base. For GMP pharmaceutical laboratory customers, a confirmed security incident may trigger their own regulatory notification obligations to the relevant medicines authority — vendor notifications should be designed to give customers sufficient information to fulfil their own regulatory obligations.

Default-category laboratory instruments may self-declare CRA conformity. Relevant harmonised standards for laboratory instrumentation include IEC 62443-4-1 (secure development lifecycle) and IEC 62443-4-2 (component security requirements), which are applicable to network-connected scientific instruments. ISO/IEC 27001 certification of the vendor's information security management system provides supporting evidence for the technical file but does not substitute for product-specific CRA conformity documentation. The technical file must include product security architecture documentation, threat model and risk assessment, SBOM, evidence of security testing, CVD policy, and the declaration of conformity. For vendors with large instrument portfolios, a modular technical file approach — with common security architecture and lifecycle documentation shared across product families — is more efficient than separate files per model.